The short answer
KLOW is stored lyophilised, cold, dry and protected from light. Light protection is required because of the copper complex. No reducing agent is needed, because none of the four components contains cysteine. TB-500, as full-length thymosin beta-4, carries one methionine that copper could oxidise, which is one more reason for cold, dry, dark storage.
Key facts
- Storage
- Lyophilised, cold, dry, dark
- Light protection
- Required (copper complex)
- Reducing agent
- Not needed (no cysteine present)
- Chelator
- Not needed (no oxidation substrate)
- Governing component
- The most sensitive of four
- Freeze-thaw
- Aliquot before freezing
One condition for four compounds
The four KLOW blend peptides share one vial and one storage environment, and the most sensitive component determines it for all of them. There is no way to give one gentler treatment than another, which is the storage expression of the same inseparability that fixes the ratio.
What requires the light protection
The copper complex. Metal complexes are generally light-sensitive and copper is redox-active, so this is a substantive requirement rather than a generic instruction. The other three components would tolerate more; in this vial they get the copper complex's conditions.
Research material referenced
KLOW 80mg, third-party HPLC tested
What is not needed, and why
No reducing agent. Copper catalyses oxidation of cysteine thiols and methionine thioethers. None of KPV, BPC-157 or TB-500 contains cysteine, so the thiol reaction has no substrate. TB-500, as full-length thymosin beta-4, does carry one methionine, the one residue in the vial copper could oxidise. That is a specific chemical fact about this particular combination rather than a general property of blends.
The asymmetry to be aware of
Surface adsorption affects the smallest component most, so KPV is disproportionately lost to glass and plastic at low concentrations. That loss changes the effective ratio silently, and it is not captured by any storage instruction or certificate figure. Low-binding consumables and minimal transfers are the practical response.
After reconstitution
Once a KLOW vial is reconstituted, four peptides each follow their own solution stability. The least stable governs the useful life of the whole preparation, since none can be used separately once combined. Aliquot into single-use volumes before freezing rather than cycling a stock: freeze-thaw damages all four and there is no selective recovery.
Frequently asked questions
Does the copper require a chelator?
No chelator is part of the storage advice. None of the four components contains cysteine; the one residue copper could oxidise is TB-500's methionine, which is why the vial is kept cold, dry and dark.
Why is light protection required?
The copper complex. Metal complexes are generally light-sensitive and copper is redox-active.
How long does it last once reconstituted?
The least stable of the four governs, since none can be used separately once combined.
Continue researching
Related guides and reference material.
Primary sources & clinical trials
Published papers, trial registrations, regulator pages and company announcements. Links open the original.
- PubMedPickart L, GHK-Cu in prevention of oxidative stress. Oxid Med Cell Longev 2012 (PMID 22666519)pubmed.ncbi.nlm.nih.gov
- PubMedStability of protein pharmaceuticals: an update. Pharm Res (PMID 20143256)pubmed.ncbi.nlm.nih.gov
- PubMedNail SL et al., Fundamentals of freeze-drying. Pharm Biotechnol 2002 (PMID 12189727)pubmed.ncbi.nlm.nih.gov
Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).
Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.
More KLOW (Blend) articles
- Four Literatures, No Combination LiteratureEach component has published work of varying quality. The combination has none. What that distinction actually means for reading claims.
- Half of This Blend Is Small Enough to Share a RouteKPV is a demonstrated PepT1 substrate. GHK is also a tripeptide. Whether the two compete for the same carrier has never been asked, let alone answered.
- What Is KLOW? KPV, GHK-Cu, BPC-157 and TB-500A four-component co-lyophilised blend at 80mg - KPV, GHK-Cu, BPC-157 and TB-500. What the fourth component adds and what it complicates.
- What You Can and Cannot Ask a Four-Component BlendA fixed ratio removes the ability to vary one component. Which experimental questions survive that, and which require separate vials.
- A Fourteenfold Size Range in One Vial342.43 Da to 1419.5 Da is the widest span in this catalogue. What that means for how the cake redissolves and what partial dissolution looks like.